Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1)
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T.
Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
1996
ISSN/ISBN: 0037-8682 PMID: 9011891 Document Number: 306990
Document emailed within 1 workday
Related Documents
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Fujii, T. 2005: Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 434-437
Lu, X.S.; Bélec, L.; Pillot, J. 1993: Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women Journal of Infectious Diseases 167(5): 1189-1192
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Maueia, C.; Costa, D.; Meggi, B.; Ismael, N.; Walle, C.; Curvo, R.; Abreu, C.; Bhatt, N.; Tanuri, A.; Jani, I.V.; Ferreira, O.C. 2011: Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique Virology Journal 8: 408
Budhachandra, Y.; Ramesh, K.; Sumitra, G. 2007: Personality profile among Human Immunodeficiency Virus (HIV) positives and Acquired Immunodeficiency Syndrome (AIDS) patients of injecting drug users Kathmandu University Medical Journal 5(1): 38-41
Reibnegger, G.; Spira, T.J.; Fuchs, D.; Werner-Felmayer, G.; Dierich, M.P.; Wachter, H. 1991: Individual probability for onset of full-blown disease in patients infected with human immunodeficiency virus type 1 Clinical Chemistry 37(3): 351-355
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Arévalo Velasco, A.; Mateo Rodríguez, F.; Sánchez Pérez, M.A.; Alonso Claudio, G.; Pérez Arellano, J.L.; Fuertes Martín, A. 1997: Iron metabolism in patient infected by human immunodeficiency virus type 1 Sangre 42(5): 345-349
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844
Arpadi, S.M.; Markowitz, L.E.; Baughman, A.L.; Shah, K.; Adam, H.; Wiznia, A.; Lambert, G.; Dobroszycki, J.; Heath, J.L.; Bellini, W.J. 1996: Measles antibody in vaccinated human immunodeficiency virus type 1-infected children Pediatrics 97(5): 653-657
Spence, M.R.; Robbins, S.M.; Polansky, M.; Schable, C.A. 1991: Seroprevalence of human immunodeficiency virus type I (HIV-1) antibodies in a family-planning population Sexually Transmitted Diseases 18(3): 143-145
Selimova, L.M.; Serebrovskaia, L.V.; Ivanova, L.A.; Nosik, D.N. 2010: CD4+ and CD8+ T-lymphocyte counts in human immunodeficiency virus type 1 subtype A-infected patients carrying mutations V77i in protease and/or A62V in reverse transcriptase Voprosy Virusologii 55(2): 22-26
Mehendale, S.M.; Bollinger, R.C.; Kulkarni, S.S.; Stallings, R.Y.; Brookmeyer, R.S.; Kulkarni, S.V.; Divekar, A.D.; Gangakhedkar, R.R.; Joshi, S.N.; Risbud, A.R.; Thakar, M.A.; Mahajan, B.A.; Kale, V.A.; Ghate, M.V.; Gadkari, D.A.; Quinn, T.C.; Paranjape, R.S. 2002: Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India Aids Research and Human Retroviruses 18(16): 1175-1179